Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-CHOEP-14 vs Mega-CHOEP-21 in Aggressive NHL (DSHNHL 2002-1)
NCT00129090Phase 3Completed
- Sponsor
- German High-Grade Non-Hodgkin Lymphoma Study Group
- Start
- Mar 2003
- Primary completion
- Oct 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in B-cell non-Hodgkin lymphoma, sponsored by German High-Grade Non-Hodgkin Lymphoma Study Group. Started Mar 2003; status: completed.
02
Drugs
rituximab
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT00129090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00129090.